June 30 (Reuters) - Profound Medical Corp PRN.V :
* Profound Medical -Philips to transfer Sonalleve MR-HIFU assets to profound for upfront consideration of 7.4 million common shares of profound at C$1.10/share
* Profound Medical Corp. Announces definitive agreement with royal philips to expand collaboration and acquire sonalleve MR-HIFU business
* Profound Medical Corp - agreement also includes certain earn-out provisions tied to future revenue levels
* Profound Medical - Philips, profound will also expand their non-exclusive strategic sales relationship to include distribution of Sonalleve MR-HIFU
* Profound Medical Corp - if successful, tact is expected to support Profound's application to fda for approval to market TULSA-PRO() in United States
* Profound Medical- TULSA-PRO is ce marked and co is also sponsoring its FDA-registered clinical trial, tact
* Profound Medical Corp - is currently conducting pilot commercial launch of Tulsa-Pro in key european, other ce mark jurisdictions Source text for Eikon: ID:nNRA42klks Further company coverage: PRN.V